SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-027527
Filing Date
2021-05-13
Accepted
2021-05-13 16:05:40
Documents
14
Period of Report
2021-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bolt-8k_20210513.htm   iXBRL 8-K 45485
2 EX-99.1 bolt-ex991_24.htm EX-99.1 371611
3 GRAPHIC gwq0fhiglcps000001.jpg GRAPHIC 3880
  Complete submission text file 0001564590-21-027527.txt   570736

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bolt-20210513.xsd EX-101.SCH 5756
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bolt-20210513_lab.xml EX-101.LAB 19458
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bolt-20210513_pre.xml EX-101.PRE 11612
7 EXTRACTED XBRL INSTANCE DOCUMENT bolt-8k_20210513_htm.xml XML 3558
Mailing Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-665-9295
Bolt Biotherapeutics, Inc. (Filer) CIK: 0001641281 (see all company filings)

IRS No.: 472804636 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39988 | Film No.: 21919568
SIC: 2834 Pharmaceutical Preparations